Expression of 5-HT_1B Receptors in Human Nasal Mucosa

References

• Habib YA, Belal A, el-Garem A, el-Lozy M, el-Banna HM, Toppozada H. Serotonin in nasal allergy. Acta Allergol 1971; 26: 39–48.
   PubMed Web of Science ®Google Scholar
• O'Connor RD, Ring J, Jalowayski AA, Hamburger RN. The in vitro effects of levamisole on lymphocyte proliferation, polymorphonuclear leucocyte chemotaxis, basophil histamine release and platelet serotonin release in patients with atopic dermatitis. Clin Allergy 1980; 10: 705–13.
   PubMedGoogle Scholar
• Hoyer D, Clarke DE, Fozard JR, et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 1994; 46: 157–203.
   PubMed Web of Science ®Google Scholar
• Saxena PR, Villalon CM. Cardiovascular effects of serotonin agonists and antagonists. J Cardiovasc Phar-macol 1990; 15 (Suppl 7): 17–34.
   PubMedGoogle Scholar
• Tönnesen P, Mygind N. Nasal challenge with serotonin and histamine in normal persons. Allergy 1985; 40: 350–3.
   Google Scholar
• Raffestin B, Cerrina J, Boullet C, Labat C, Benveniste J, Brink C. Response and sensitivity of isolated human pulmonary muscle preparations to pharmacological agents. J Pharmacol Exp Ther 1985; 233: 186–94.
   PubMed Web of Science ®Google Scholar
• Stone RA, Worsdell YM, Fuller RW, Barnes PJ. Effects of 5-hydroxytryptamine and 5-hydroxytryptophan infu-sion on the human cough reflex. J Appl Physiol 1993; 74: 396–401.
   PubMed Web of Science ®Google Scholar
• Plassat JL, Boschert U, Amlaiky N, Hen R. The mouse 5HT5 receptor reveals a remarkable heterogeneity within the 5HTID receptor family. EMBO J 1992; 11: 4779–86.
   PubMed Web of Science ®Google Scholar
• Xie Z, Lee SP, O'Dowd BF, George SR. Serotonin 5-HT111 and 5-HTID receptors form homodimers when expressed alone and heterodimers when co-expressed. FEBS Lett 1999; 456: 63–7.
   Google Scholar
• Hartig PR, Branchek TA, Weinshank RL. A subfamily of 5-HTID receptor genes. Trends Pharmacol Sci 1992; 13: 152–9.
   PubMed Web of Science ®Google Scholar
• Zgombick JM, Bard JA, Kucharewicz SA, Urquhart DA, Weinshank RL, Branchek TA. Molecular cloning and pharmacological characterization of guinea-pig 5-HT111 and 5-HTID receptors. Neuropharmacology 1997; 36: 513–24.
   PubMed Web of Science ®Google Scholar
• Bonaventure P, Voorn P, Luyten WH, Jurzak M, Schotte A, Leysen JE. Detailed mapping of serotonin 5-HTIB and 5-HTID receptor messenger RNA and ligand binding sites in guinea-pig brain and trigeminal ganglion: clues for function. Neuroscience 1998; 82: 469–84.
   PubMed Web of Science ®Google Scholar
• Nilsson T, Longmore J, Shaw D, et al. Characterisation of 5-HT receptors in human coronary arteries by molec-ular and pharmacological techniques. Eur J Pharmacol 1999; 372: 49–56.
   PubMed Web of Science ®Google Scholar
• Maassen van den Brink A, Reekers M, Bax WA, Ferrari MD, Saxena PR. Coronary side-effect potential of current and prospective antimigraine drugs. Circulation 1998; 98: 25–30.
   Google Scholar
• Humphrey PPA, Feniuk W. Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol Sci 1991; 12: 444–6.
   PubMed Web of Science ®Google Scholar
• Weinshank RL, Zgombick JM, Macchi M, Branchek TA, Hartig PR. Human serotonin 1D receptor is en-coded by a subfamily of two distinct genes: 5-HT1Da and 5-HT1Df3. Proc Natl Acad Sci USA 1992; 89: 3630–4.
   Google Scholar
• Ferrari MD, Saxena PR. 5-HT1 receptors in migraine pathophysiology and treatment Eur J Neurol 1995; 2: 5–21.
   Google Scholar
• Ferrari MD. Migraine. Lancet 1998; 351: 1043–51.
   PubMed Web of Science ®Google Scholar
• Brown EG, Endersby CA, Smith RN, Talbot JC. The safety and tolerability of sumatriptan: an overview. Eur Neurol 1991; 31: 339–44.
   PubMed Web of Science ®Google Scholar
• Hamel E, Fan E, Linville D, Ting V, Villemure JG, Chia LS. Expression of mRNA for the serotonin 5-hydrox-ytryptamine 1D receptor subtype in human and bovine cerebral arteries. Mol Pharmacol 1993; 44: 242–6.
   PubMed Web of Science ®Google Scholar
• Jansen I, Ole sen J, Edvinsson L. 5-Hydroxytryptamine receptor characterisation of human cerebral, middle meningeal and temporal arteries: regional differences. Acta Physiol Scand 1993; 147: 141–50.
   PubMedGoogle Scholar
• Nilsson T, Longmore J, Shaw D, Jansen-Olesen I, Edvinsson L. Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localisation with immunocytochemistry. Br J Pharmacol 1999; 128: 1133–40.
   Google Scholar
• Rebeck GW, Maynard KI, Hyman BT, Moskowitz MA. Selective 5-HTID„ serotonin receptor gene expres-sion in trigeminal ganglia: Implications for antimigraine drug development. Proc Natl Acad Sci USA 1994; 91: 3666–9.
   PubMed Web of Science ®Google Scholar
• Bouchelet I, Cohen Z, Bruce C, Seguela P, Hamel E. Differential expression of sumatriptan-sensitive 5-hy-droxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Mol Pharmacol 1996; 50: 219–23.
   Google Scholar
• Longmore J, Shaw D, Smith D, et al. Differential distribution of 5-HT1D- and 5HT1g-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs. Cephalalgia 1997; 17: 833–42.
   PubMed Web of Science ®Google Scholar
• Tönnesen P. Bronchial challenge with serotonin in asthmatics. Allergy 1985; 40: 136–40.
   PubMed Web of Science ®Google Scholar
• Tönnesen P. Effect of topically applied atropine, methy-sergide and chlorpheniramine on nasal challenge with serotonin. Allergy 1985; 40: 616–9.
   PubMed Web of Science ®Google Scholar
• Tönnesen P, Hindberg I. Serotonin in nasal secretion. Allergy 1988; 43: 303–9.
   Google Scholar
• Tönnesen P, Hindberg I, Schaffalitzky de Muckadell OB, Mygind N. Effect of nasal allergen challenge on serotonin, substance P and vasoactive intestinal peptide in plasma and nasal secretions. Allergy 1988; 43: 310–7.
   Google Scholar